By Min Wu
The European Patent Office (EPO) published a decision rejecting an attempt to
patent human foreskin cells suitable for
culturing stem cells, according to IP-Watch. The EPO said in its decision that inventions using human
embryonic stem cell lines derived from the destruction of the human embryos are
not patentable under the European Patent Convention.
In 2011, the European Court of Justice (ECJ) ruled
that no patents may be issued on stem cell research if human embryos have been
destroyed in the process. Although the ruling is not binding on the EPO, the
EPO observed that its decision is consistent with the ECJ ruling.
0 comments:
Post a Comment